Warfarin Sensitivity Testing: Medco/Mayo Study Results Due Early 2010

Pharmacy benefit manager Medco plans to release an observational study on the benefits of pharmacogenomic testing in warfarin dosing in early 2010. It hopes the results will increase payer acceptance of the approach to treatment